BioNTech COO Sean Marett Reveals How To Spend $270M

12 Apr 2018

• By Mike Ward

BioNTech AG raised $270m in a series A venture round at the start of 2018 as it pursues an ambition to create a fully integrated biopharmaceutical company. COO Sean Marett tells Scrip how the funds will be invested.

Sean Marett, BioNTech COO • Source: BioNTech

BioNTech COO Sean Marett Reveals How To Spend $270M

More from Start-Ups & SMEs

More from Business